13th January 2022
- 0 comments
ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor's office, has closed a €30 million Series A equity financing co-led by Gilde Healthcare Partners and Lightstone Ventures, including participation from existing investors.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.